Larvol Delta - BPGbio-Announces-Completion-of-Enrollment-for-Phase-2b-Trial-of-BPM31510-for-Glioblastoma-GBM

ubidecarenone IV (BPM31510 IV) - BPGbio

https://www.globenewswire.com/news-release/2025/09/04/3144357/0/en/BPGbio-Announces-Completion-of-Enrollment-for-Phase-2b-Trial-of-BPM31510-for-Glioblastoma-GBM.html

Sep 4, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next